Succinobucol
Succinobucol Uses, Dosage, Side Effects, Food Interaction and all others data.
AGI-1067, is a novel small molecule with anti-oxidant and anti-inflammatory properties that was discovered by AtheroGenics and designed to treat atherosclerosis of the blood vessels of the heart, or coronary artery disease.
| Trade Name | Succinobucol |
| Generic | Succinobucol |
| Succinobucol Other Names | Succinobucol |
| Type | |
| Formula | C35H52O5S2 |
| Weight | Average: 616.914 Monoisotopic: 616.325616154 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Uses
Investigated for use/treatment in atherosclerosis, coronary artery disease, diabetes mellitus type 2, and in-stent restenosis.
How Succinobucol works
AGI-1067 works by inhibiting key oxidant signals within cells of blood vessel walls that generate inflammatory processes that are key to the pathogenesis of atherosclerosis. This includes inhibition of inflammatory cytokines, chemokines and vascular adhesion molecules that participate in the initiation, growth and eventual destabilization of the plaque. Its anti-oxidant properties also play a role in its ability to inhibit the formation of oxidized LDL, a critical component in the formation of atherosclerotic plaque.
Innovators Monograph
You find simplified version here Succinobucol
